User profiles for Gunnar Houge
Gunnar HougeProfessor, Dep med genetics, Haukeland University Hospital Verified email at helse-bergen.no Cited by 9057 |
Formation of new chromatin domains determines pathogenicity of genomic duplications
Chromosome conformation capture methods have identified subchromosomal structures of
higher-order chromatin interactions called topologically associated domains (TADs) that are …
higher-order chromatin interactions called topologically associated domains (TADs) that are …
[PDF][PDF] Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary …
…, JL Tolmie, D Chitayat, G Houge… - The American Journal of …, 2007 - cell.com
We observed two unrelated consanguineous families with malformation syndromes sharing
anophthalmia and distinct eyebrows as common signs, but differing for alveolar capillary …
anophthalmia and distinct eyebrows as common signs, but differing for alveolar capillary …
Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus
Coats plus is a highly pleiotropic disorder particularly affecting the eye, brain, bone and
gastrointestinal tract. Here, we show that Coats plus results from mutations in CTC1, encoding …
gastrointestinal tract. Here, we show that Coats plus results from mutations in CTC1, encoding …
[HTML][HTML] Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg
AC Vedder, GE Linthorst, G Houge, JEM Groener… - PloS one, 2007 - journals.plos.org
Background Two different enzyme preparations, agalsidase alfa (Replagal TM , Shire) and
beta (Fabrazyme TM , Genzyme), are registered for treatment of Fabry disease. We compared …
beta (Fabrazyme TM , Genzyme), are registered for treatment of Fabry disease. We compared …
Agalsidase benefits renal histology in young patients with Fabry disease
…, KK Larsen, A Hirth, BE Vikse, G Houge… - Journal of the …, 2013 - journals.lww.com
The effect of early-onset enzyme replacement therapy on renal morphologic features in
Fabry disease is largely unknown. Here, we evaluated the effect of 5 years of treatment with …
Fabry disease is largely unknown. Here, we evaluated the effect of 5 years of treatment with …
Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis
Mechanotransduction, the pathway by which mechanical forces are translated to biological
signals, plays important but poorly characterized roles in physiology. PIEZOs are recently …
signals, plays important but poorly characterized roles in physiology. PIEZOs are recently …
The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells
R Bøe, BT Gjertsen, OK Vintermyr, G Houge… - Experimental cell …, 1991 - Elsevier
Okadaic acid, a specific and potent inhibitor of protein phosphatases 2A and 1, was tested
for its effect on the morphology of a number of cell types: freshly isolated rat hepatocytes in …
for its effect on the morphology of a number of cell types: freshly isolated rat hepatocytes in …
A comprehensive molecular study on Coffin–Siris and Nicolaides–Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered …
…, E Guillén-Navarro, J Hayek, G Houge… - Human molecular …, 2013 - academic.oup.com
Chromatin remodeling complexes are known to modify chemical marks on histones or to
induce conformational changes in the chromatin in order to regulate transcription. De novo …
induce conformational changes in the chromatin in order to regulate transcription. De novo …
CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta
…, A Green, H Robinson, M Michelson, G Houge… - Human …, 2008 - Wiley Online Library
Autosomal dominant osteogenesis imperfecta (OI) is caused by mutations in the genes (COL1A1
or COL1A2) encoding the chains of type I collagen. Recently, dysregulation of …
or COL1A2) encoding the chains of type I collagen. Recently, dysregulation of …
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype
…, WM Nillesen, V Cormier-Daire, G Houge… - Journal of medical …, 2009 - jmg.bmj.com
Background: The 9q subtelomeric deletion syndrome (9qSTDS) is clinically characterised
by moderate to severe mental retardation, childhood hypotonia and facial dysmorphisms. In …
by moderate to severe mental retardation, childhood hypotonia and facial dysmorphisms. In …